Chawla Medicos

Chawla Medicos is a prominent player in the Health Care and Pharmaceutical industries, with a core focus on exporting pharmaceutical drugs from India to global markets. Established in 2016, the company specializes in providing crucial medications for life-threatening illnesses such as Hepatitis C, Anti-Cancer, and HIV. Their commitment to offering authentic, efficient, and high-quality products at cost-effective prices has positioned them as certified distributors of life-saving drugs. Chawla Medicos' emphasis on direct exports and dedication to ensuring the safety and efficacy of their products has earned them recognition as a leading exporter of a wide range of medications, including Sofosbuvir (Sovaldi), Daclatasvir, and Harvoni (Ledipasvir & Sofosbuvir). Their offerings extend to include Tenvir and Entecavir, among others, addressing critical medical needs on a global scale. While the details of their last investment are not available, Chawla Medicos' dedication to delivering essential pharmaceuticals with a particular focus on diseases with high global prevalence underscores their potential for continued growth and impact in the healthcare landscape.